Debates & Insights

Marketing science – brand innovation for pharma

Combining fields such as economics, statistics and operations research, marketing science has for some time operated under-the-radar as

Marketing science – brand innovation for pharma

https://pharmaphorum.com/debates-insight-sales-marketing/marketing-science-brand-innovation-for-pharma/

Digital health: how can technology be used to engage hard-to-reach patients and assist with patient monitoring?

Helping someone live with a condition as complex as MS can be fraught with challenges. MS professionals are

Digital health: how can technology be used to engage hard-to-reach patients and assist with patient monitoring?

https://pharmaphorum.com/debates-insight-digital/digital-health-can-technology-used-engage-hard-reach-patients-assist-patient-monitoring/

New report: Are clinical trials under threat from ‘system overload’?

The 2017 Unified Clinical Operations Survey Report Nearly all (99%) of clinical operations professionals who responded to the

New report: Are clinical trials under threat from ‘system overload’?

https://pharmaphorum.com/debates-insight-market-access/new-report-clinical-trials-threat-system-overload/

20/06/2017

Disruption and maturity: the future directions for biologics

Is the UK’s NHS saving enough from the new wave of biosimilars?

Disruption and maturity: the future directions for biologics

https://pharmaphorum.com/debates-insight-market-access/disruption-maturity-future-directions-biologics/

The future of the clinical trial: collaboration and patient centricity

Growing patient influence combined with new technologies and the requirements of new reimbursement models means clinical research

The future of the clinical trial: collaboration and patient centricity

https://pharmaphorum.com/debates-insight-patients/future-clinical-trial-collaboration-patient-centricity/

10/03/2017

Approval and access: overcoming the final hurdle of drug development

2017 is likely to be a year of significant change for pharma brands in Europe. With affordability on the agenda for

Approval and access: overcoming the final hurdle of drug development

https://pharmaphorum.com/debates-insight-market-access/european-market-access-overcoming-final-hurdle-drug-development/

Available on demand: Measuring the cost of the right interventions in diabetes

Available on Demand: Measuring the cost of the right interventions in diabetes.

Available on demand: Measuring the cost of the right interventions in diabetes

https://pharmaphorum.com/debates-insight-patients/measuring-cost-right-interventions-diabetes/

Available on demand: Transform Medical Affairs initiatives with fact-based solutions

This webinar will explore the challenges Medical Affairs teams have finding a repeatable, objective and compliant solution to identify and manage their strategic programmes.

Available on demand: Transform Medical Affairs initiatives with fact-based solutions

https://pharmaphorum.com/debates-insight-sales-marketing/live-webinar-transform-medical-affairs-initiatives-with-fact-based-solutions-for-improved-compliance/

Available on demand: What does ‘the cloud’ mean for pharma?

It is likely that you interact with ‘the cloud’ on various devices, multiple times throughout the day.

Available on demand: What does ‘the cloud’ mean for pharma?

https://pharmaphorum.com/debates-insight-digital/available-on-demand-what-does-the-cloud-mean-for-pharma/

1 2

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Search

Advanced Search

Trending

Debates & Insights